Profile
ALVO ZTS HLN TAK TEVA VTRS
Company Name Alvotech Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $3.60B $79.84B $43.93B $42.42B $19.40B $15.82B
Employees 1.00K 14.10K 25.41K 49.28K 37.00K 32.00K
CEO Mr. Robert Wessman Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Mr. Scott Andrew Smith Ph.D.
Ratings
ALVO ZTS HLN TAK TEVA VTRS
Quant Rating Score 2 3 3 3 1 3
Quant Rating Sell Neutral Neutral Neutral Strong Sell Neutral
Trading
ALVO ZTS HLN TAK TEVA VTRS
Last Close $11.99 $176.96 $9.65 $13.38 $17.12 $13.37
High 52 $17.27 $199.94 $10.69 $15.08 $18.96 $13.53
Low 52 $10.76 $145.54 $8.01 $12.6 $10.44 $10.05
Price vs. 52 Week High -30.57 % -11.49 % -9.73 % -11.27 % -9.7 % -1.18 %
Price vs. 52 Week Low 11.43 % 21.59 % 20.47 % 6.19 % 63.98 % 33.03 %
Total Return
ALVO ZTS HLN TAK TEVA VTRS
1 Month Return -7.05 % -6.37 % -2.53 % -3.46 % -7.01 % 15.76 %
3 Month Return 0.84 % -2.18 % -2.53 % -11.27 % -7.76 % 13.69 %
6 Month Return -11.71 % 3.55 % 14.07 % 2.76 % 2.15 % 26.97 %
9 Month Return -25.2 % -10.27 % 14.74 % -8.48 % 32.82 % -1.18 %
YTD Return 4.44 % -10.34 % 17.25 % -6.24 % 63.98 % 23.45 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALVO ZTS HLN TAK TEVA VTRS
Dividend Yield Percentage (TTM) - 0.98 % 1.62 % 4.67 % - 3.62 %
Dividend Paid and Capex Coverage Ration (TTM) -7.27 % 2.1 % - 1.34 % 5.06 % 2.39 %
Dividend Per Share (TTM) - 1.73 % 0.06 % 192 % - 0.48 %
Payout Ratio (TTM) - 31.44 % - 101.62 % - -65.15 %
Growth
ALVO ZTS HLN TAK TEVA VTRS
Asset Growth 14.68 % -4.28 % -2.18 % 8.25 % -1.2 % -4.67 %
Gross Profit Growth -466.65 % 3.7 % 5.85 % -16.6 % 9.64 % -0.9 %
Revenue Growth 10.12 % 5.74 % 4.09 % 5.87 % 6.16 % -5.14 %
Revenue 3 Year -81.13 % 31.98 % 13.9 % 33.13 % -6.92 % -35.32 %
Revenue 5 Year 207.13 % 53.64 % 32.87 % 149.89 % -23.33 % -41.73 %
Revenue 10 Year 207.13 % 103.1 % 32.87 % 154.38 % -40.82 % -26.57 %
EBIT Growth -2.43 % 6.27 % 37.26 % 7.34 % -84.52 % -52.55 %
Net Income Growth -7.43 % 10.88 % -1.04 % -54.56 % 76.24 % -97.37 %
Net Income 3 Yeari Growth Per Share 55.38 % 47.55 % -8.67 % -61.74 % 86.29 % 104.09 %
Net Income 5 Yeari Growth Per Share -181.85 % 71.94 % 59.66 % 62.27 % 76.28 % -93.3 %
Net Income 10 Yeari Growth Per Share -181.85 % 404.24 % 59.66 % 36.33 % -133.42 % -97.12 %
Operating Income Growth -2.43 % 6.27 % 37.26 % 7.34 % -84.52 % -52.55 %
Operating Cash Flow Growth (CFG) 0.07 % 23.06 % -16.48 % -34.47 % -13.96 % -5.18 %
Operating 3 Year CFG 42.22 % 14.12 % 22.08 % -36.76 % 10.09 % 13.84 %
Operating 5 Year CFG -277.99 % 37.69 % 118.54 % 139.61 % -48.98 % -48.37 %
Operating 10 Year CFG -277.99 % 274.61 % 118.54 % 335.67 % -67.94 % -16.8 %
EPS Growth 6.54 % 12.64 % - -54.92 % 76.42 % -97.08 %
EPS Diluted Growth 6.54 % 12.92 % - -54.86 % 76.42 % -97.08 %
Book Value Per Share -43.74 % 15.25 % 1.35 % 13.54 % -7.25 % -1.92 %
Share Holder 3 Year Equity Growth Per Share 85.21 % 36.7 % -36.6 % 40.38 % -26.74 % -55.34 %
Share Holder 5 Year Equity Growth Per Share - 139.55 % -39.41 % 73.27 % -53.44 % -27.35 %
Share Holder 10 Year Equity Growth Per Share - 476.36 % -39.41 % 197.1 % -74.76 % 128.81 %
Dividend Per Share Growth - 15.15 % -85.58 % 1.95 % - -0.06 %
Dividend 3 Year Growth Per Share - 87.76 % -83.69 % 1.19 % - -
Dividend 5 Year Growth Per Share - 198.29 % -66.42 % 146.94 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % -66.42 % 103.93 % -100 % -
Debt Growth 33.58 % -15.91 % -9.43 % 24.67 % -6.53 % -5.93 %
Free Cash Flow Growth 0.76 % 22.25 % -20.06 % -53.54 % -19.19 % -7.35 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023
Profitability
ALVO ZTS HLN TAK TEVA VTRS
Gross Profit Margin TTM 56.08 % 68.87 % 59.91 % 55.23 % 49.87 % 40.26 %
Return on Assets TTM -35.8 % 16.93 % 3.26 % 1.99 % -2.38 % -1.97 %
Return on Equity TTM 69.49 % 47.99 % 6.54 % 4.04 % -14.58 % -4.43 %
Return on Capital Employed TTM -4.24 % 26.64 % 7.22 % 4.18 % 7.66 % -0.71 %
Net Income Per EBT TTM 91.6 % 79.65 % 65.38 % 108.74 % 175.89 % 92.81 %
EBT Per Ebit TTM 1060.5 % 90.51 % 82.95 % 52.35 % -26.34 % 359.67 %
EBIT Per Revenue TTM -12.37 % 36.83 % 17.82 % 11.21 % 12.76 % -1.76 %
Cash Flow To Debt Ratio TTM -25.76 % 44.8 % - 16.58 % 13 % 13.05 %
Receivables Turnover TTM 2.52 6.49 5.27 6.3 4.85 4.04
Payables Turnover TTM 2.8 7.05 1.25 4.92 3.55 7.23
Inventory Turnover TTM 1.29 1.18 3.09 1.69 2.13 2.2
Fixed Asset Turnover TTM 89.87 % 259.93 % 604.62 % 240.84 % 278.05 % 561.67 %
Asset Turnover TTM 29.8 % 63.75 % 33.71 % 31.2 % 40.19 % 33.6 %
Operating Cash Flow Per Share TTM -1 6.5 - 528.88 2.18 1.93
Free Cash Flow Per Share TTM -1.14 5.1 - 321.24 1.75 1.6
Cash Per Share TTM 44.78 % 378.45 % 5.72 % 54259.65 % 292.94 % 157.41 %
Operating Cash Flow Sales Ratio TTM -72.06 % 32.18 % - 18.42 % 14.71 % 15.29 %
Free Cash Flow Operating Cash Flow Ratio TTM 113.75 % 78.37 % - 60.74 % 80.23 % 83.19 %
Cash Flow Coverage Ratios TTM -25.76 % 44.8 % - 16.58 % 13 % 13.05 %
Price To Free Cash Flows Ratio TTM -11.95 34.59 - 12.82 9.8 8.27
Price To Operating Cash Flows Ratio TTM -11.91 27.21 - 7.78 7.86 6.88
Price Cash Flow Ratio TTM -11.91 27.21 - 7.78 7.86 6.88
Income Statement (TTM)
ALVO ZTS HLN TAK TEVA VTRS
Revenue $0.09B $8.54B $11.3B $4263.76B $15.85B $15.43B
Gross Profit $-0.07B $5.83B $6.96B $2321.31B $7.65B $6.44B
Gross Profit Ratio -75.93% 68.28% 61.6% 54.44% 48.25% 41.74%
EBITDA $-0.48B $3.69B $2.35B $900.33B $4.33B $3.52B
Net Income $-0.55B $2.34B $1.05B $144.07B $-0.56B $0.05B
EPS Diluted -2.43 5.07 0.11 91.16 -0.5 0.05
Balance Sheet (MRQ)
ALVO ZTS HLN TAK TEVA VTRS
Long Term Debt $1.03B $6.75B $8.95B $5029.93B $18.48B $16.35B
Total Liabilities $1.88B $9.3B $17.33B $7834.79B $35.35B $27.22B
Total Equity $-0.93B $4.99B $16.73B $7274.01B $8.13B $20.47B
Total Investments $0.02B $0.02B $0.07B $683.22B $0.01B $1.33B
Total Debt $1.08B $6.76B $9.46B $5463.39B $20.15B $18.37B
Total Assets $0.95B $14.29B $34.06B $15108.79B $43.48B $47.69B
Cash Flow Statement (TTM)
ALVO ZTS HLN TAK TEVA VTRS
Net Income $-0.55B $2.34B $1.05B $144.07B $-0.62B $0.05B
Inventory $-0.01B $-0.36B $-0.13B $-115.74B $0B $-0.61B
Dividends Paid $0B $-0.69B $-0.39B $-287.19B $0B $-0.58B
Operating Cash Flow $-0.31B $2.35B $1.72B $640.32B $1.37B $2.8B
Capital Expenditure $-0.05B $-0.73B $-0.34B $-480.73B $-0.53B $-0.47B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.34
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.36
ALIM Alimera Sciences, Inc. 5.54
ALVOW Alvotech 3
AMPH Amphastar Pharmaceuticals, Inc. 45.46
AMRX Amneal Pharmaceuticals, Inc. 8.39
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 56.91
AQST Aquestive Therapeutics, Inc. 4.56
ASRT Assertio Holdings, Inc. 0.9408
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 11.66
AYTU Aytu BioPharma, Inc. 1.63
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to ALVO
Ticker ETF Name Weight Percentage Price
VWO Vanguard Emerging Markets Stock Index Fund 0.01 45.41
VEU Vanguard FTSE All-World ex-US Index Fund 0 59.19
VT Vanguard Total World Stock Index Fund 0 120.59
VXUS Vanguard Total Intl Stock Idx Fund 0 60.91
SCHE Schwab Emerging Markets Equity ETF 0.0115551 27.6
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 74.95
DWAS Invesco DWA SmallCap Momentum ETF 0.199 102.69
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.12 26.24
SPAK Defiance Next Gen SPAC Derived ETF 0.14 14.63
VTSNX Vanguard Total Intl Stock Idx Fund 0 130.78
STXK Ea Series Trust - Strive 2000 ETF 0.04 33.6613
VFWAX Vanguard FTSE All-World ex-US Index Fd Admiral 0 36.79
VEMAX Vanguard Emerging Markets Stock Index Fund Admiral Shares 0.01 37.79
VTIAX Vanguard Total International Stock Index Fd Admiral 0 32.7
VTWAX Vanguard Total World Stock Index Fund Admiral Shares 0 42.68
VEMRX Vanguard Emerging Mkts Stock Idx InsPlus 0.01 95.59
VTWIX Vanguard Total World Stock Index I 0 246.04
VTPSX Vanguard Total Intl Stock Idx InstlPls 0 130.81
RFLR Innovator ETFs Trust 0.06 27.05
Unlock